ENVA vs. PFE
ENVA (Enova International, Inc.) and PFE (Pfizer Inc.) are both stocks. ENVA operates in Credit Services (Financial Services), while PFE operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, ENVA returned 38.77%/yr vs 2.11%/yr for PFE. At a 0.17 correlation, their price movements are largely independent.
Performance
ENVA vs. PFE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ENVA achieves a 20.44% return, which is significantly higher than PFE's 8.79% return. Over the past 10 years, ENVA has outperformed PFE with an annualized return of 38.77%, while PFE has yielded a comparatively lower 2.11% annualized return.
ENVA
- 1D
- -0.14%
- 1M
- 13.51%
- YTD
- 20.44%
- 6M
- 16.35%
- 1Y
- 102.88%
- 3Y*
- 53.36%
- 5Y*
- 39.68%
- 10Y*
- 38.77%
PFE
- 1D
- 0.15%
- 1M
- 1.79%
- YTD
- 8.79%
- 6M
- 4.79%
- 1Y
- 14.27%
- 3Y*
- -7.78%
- 5Y*
- -3.35%
- 10Y*
- 2.11%
ENVA vs. PFE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ENVA Enova International, Inc. | 20.44% | 63.95% | 73.19% | 44.28% | -6.32% | 65.36% | 2.95% | 23.64% | 28.03% | 21.12% |
PFE Pfizer Inc. | 8.79% | 0.65% | -2.22% | -41.26% | -10.41% | 66.70% | 3.07% | -6.91% | 24.82% | 15.90% |
Correlation
The correlation between ENVA and PFE is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.14 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Nov 13, 2014 | 0.17 |
Fundamentals
ENVA:
$4.99B
PFE:
$150.21B
ENVA:
$12.29
PFE:
$1.31
ENVA:
15.40
PFE:
19.98
ENVA:
0.83
PFE:
0.36
ENVA:
1.53
PFE:
2.36
ENVA:
3.56
PFE:
1.67
ENVA:
$3.28B
PFE:
$63.32B
ENVA:
$1.23B
PFE:
$43.91B
ENVA:
$456.13M
PFE:
$16.94B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ENVA vs. PFE — Risk / Return Rank
ENVA
PFE
ENVA vs. PFE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Enova International, Inc. (ENVA) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ENVA | PFE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.06 | ||
| Sortino ratioReturn per unit of downside risk | +2.21 | ||
| Omega ratioGain probability vs. loss probability | 1.40 | 1.12 | +0.29 |
| Calmar ratioReturn relative to maximum drawdown | 4.04 | 1.13 | +2.92 |
| Martin ratioReturn relative to average drawdown | 10.44 | 2.27 | +8.16 |
Loading charts...
Drawdowns
ENVA vs. PFE - Drawdown Comparison
The maximum ENVA drawdown since its inception was -84.26%, which is greater than PFE's maximum drawdown of -69.24%. Use the drawdown chart below to compare losses from any high point for ENVA and PFE.
Loading charts...
Drawdown Indicators
| ENVA | PFE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -84.26% | -69.24% | -15.02% |
Max Drawdown (1Y)Largest decline over 1 year | -24.75% | -11.47% | -13.28% |
Max Drawdown (3Y)Largest decline over 3 years | -37.01% | -40.43% | +3.42% |
Max Drawdown (5Y)Largest decline over 5 years | -42.84% | -58.96% | +16.12% |
Max Drawdown (10Y)Largest decline over 10 years | -77.57% | -58.96% | -18.61% |
Current DrawdownCurrent decline from peak | -0.14% | -45.68% | +45.54% |
Average DrawdownAverage peak-to-trough decline | -31.82% | -22.90% | -8.92% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.57% | 5.70% | +3.87% |
Volatility
ENVA vs. PFE - Volatility Comparison
Enova International, Inc. (ENVA) has a higher volatility of 11.26% compared to Pfizer Inc. (PFE) at 5.07%. This indicates that ENVA's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ENVA | PFE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.26% | 5.07% | +6.19% |
Volatility (6M)Calculated over the trailing 6-month period | 28.77% | 14.62% | +14.15% |
Volatility (1Y)Calculated over the trailing 1-year period | 38.58% | 23.84% | +14.74% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 40.33% | 25.48% | +14.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.25% | 23.89% | +25.36% |
Dividends
ENVA vs. PFE - Dividend Comparison
ENVA has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 6.56%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ENVA Enova International, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PFE Pfizer Inc. | 6.56% | 6.91% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% |
Financials
ENVA vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Enova International, Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ENVA vs. PFE - Profitability Comparison
ENVA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Enova International, Inc. reported a gross profit of 0.00 and revenue of 875.14M. Therefore, the gross margin over that period was 0.0%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a gross profit of 9.72B and revenue of 14.45B. Therefore, the gross margin over that period was 67.3%.
ENVA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Enova International, Inc. reported an operating income of 207.11M and revenue of 875.14M, resulting in an operating margin of 23.7%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported an operating income of 4.03B and revenue of 14.45B, resulting in an operating margin of 27.9%.
ENVA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Enova International, Inc. reported a net income of 91.10M and revenue of 875.14M, resulting in a net margin of 10.4%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a net income of 2.69B and revenue of 14.45B, resulting in a net margin of 18.6%.
Frequently Asked Questions
ENVA and PFE have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ENVA has higher volatility (11.26%) compared to PFE (5.07%). In terms of maximum drawdown, ENVA dropped -84.26% vs PFE's -69.24%.
ENVA currently has the higher Sharpe Ratio (2.60 vs 0.54), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ENVA and PFE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer